Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-167
Closed -$14K 256
2015
Q4
$14K Buy
+167
New +$14K 0.06% 190
2015
Q3
Sell
-941
Closed -$80K 207
2015
Q2
$80K Sell
941
-505
-35% -$43.2K 0.33% 113
2015
Q1
$115K Sell
1,446
-104
-7% -$7.82K 0.46% 95
2014
Q4
$113K Sell
1,550
-176
-10% -$12.1K 0.45% 95
2014
Q3
$106K Sell
1,726
-180
-9% -$12.3K 0.44% 99
2014
Q2
$131K Buy
1,906
+787
+70% +$53.4K 0.55% 63
2014
Q1
$76K Buy
1,119
+479
+75% +$30.6K 0.34% 121
2013
Q4
$38K Buy
+640
New +$37K 0.17% 159
2013
Q3
Sell
-902
Closed -$46K 199
2013
Q2
$46K Buy
+902
New +$42.3K 0.21% 146

Other funds holding APTV

New York Life Trust's APTV Position: Q1 2016 in Review

New York Life Trust sold out of Aptiv (APTV) in Q1 2016, closing a stake of 167 shares — an estimated $14K sold.

New York Life Trust first reported a position in APTV in Q2 2013 and held it in 9 quarters. The position peaked at $131K in Q2 2014. 475 funds tracked by Wall St. Rank hold APTV as of Q1 2016.

  • New York Life Trust reported no remaining Aptiv position as of Q1 2016 after selling out during the quarter.
  • New York Life Trust sold 167 Aptiv shares in Q1 2016, an estimated $14K.
  • New York Life Trust first reported a position in Aptiv in Q2 2013 and held it in 9 quarters.
  • New York Life Trust's Aptiv position peaked at $131K in Q2 2014.
  • 475 funds tracked by Wall St. Rank held Aptiv as of Q1 2016.

Based on New York Life Trust's 13F filing for Q1 2016, filed 16 May 2016.